February 20, 2026

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 14.7% Revenue Growth Amidst Valuation Challenges

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly within the medical care facilities industry, is making waves with a notable 14.7% revenue growth. Headquartered in..

Talkspace, Inc. (TALK) Stock Analysis: Robust Revenue Growth and Analyst Optimism Signal Investment Potential

Talkspace, Inc. (NASDAQ: TALK), a prominent player in the Health Information Services industry, has been making waves in the virtual behavioral healthcare sector. With a market capitalization of $808.87 million,..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech with 120% Upside Potential

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing the attention of investors with a compelling growth narrative and a significant potential upside of 120.66%. Headquartered in Cambridge, Massachusetts, this clinical-stage biopharmaceutical..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a Potential 141% Upside in the Healthcare Sector

Nutex Health Inc. (NUTX), a key player in the healthcare sector specializing in medical care facilities, is capturing the attention of investors with its compelling growth story and promising financial..

AxoGen, Inc. (AXGN): Growth Potential in the Healthcare Sector with a Promising 7.40% Upside

AxoGen, Inc. (NASDAQ: AXGN), a notable player in the healthcare sector, is making waves within the medical devices industry. With a market capitalization of $1.76 billion, this Florida-based company is..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Unveiling a 110% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the healthcare sector, has been capturing the interest of investors with its innovative approach to cell-based therapies. Operating within the biotechnology..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry, has captured the attention of investors with its innovative approach..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: 44.68% Potential Upside Amidst Innovative Diagnostics Growth

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at an intriguing juncture for investors, particularly those with an appetite for innovation-driven growth in the healthcare sector. Operating primarily in the diagnostics and..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking a 129.65% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its focus on innovative gene therapies for central nervous system diseases...

Owens & Minor, Inc. (OMI) Stock Analysis: Is Nearly 94% Upside Within Reach?

For investors seeking opportunities in the healthcare sector, Owens & Minor, Inc. (NYSE: OMI) presents a compelling case. The company, a long-standing player in the medical distribution industry, currently sports..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: 82.95% Potential Upside Captures Investor Attention

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering force in the biotechnology sector, is drawing investor interest with a striking potential upside of 82.95%. As a clinical-stage gene editing company headquartered..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Investors Eye 113.97% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is garnering attention from investors with its promising pipeline in the biotechnology sector, notably targeting diseases with unmet needs. As a biopharmaceutical company based in..

Ardelyx, Inc. (ARDX) Stock Analysis: A Biotech Gem with 118% Upside Potential

Ardelyx, Inc. (NASDAQ: ARDX) is a prominent player in the biotechnology sector, specifically targeting unmet medical needs through innovative therapies. With a market capitalization of $1.64 billion, this Waltham, Massachusetts-based..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring Growth Potential Amid a 4.91% Upside

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry, offering essential home health and hospice services across the United States. With a..

Valneva SE (VALN) Stock Analysis: A Vaccine Innovator with a 21% Upside Potential

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development and commercialization of vaccines, is making significant strides in the healthcare industry. Despite its current challenges, the company..

NeuroPace, Inc. (NPCE) Stock Analysis: Exploring the 34.58% Potential Upside with Strong Buy Ratings

Investors looking to capitalize on growth within the healthcare sector should turn their attention to NeuroPace, Inc. (NASDAQ: NPCE), a prominent player in the medical devices industry. With a market..

Dianthus Therapeutics, Inc. (DNTH): Analyst Consensus Points to a Promising 46.82% Upside Potential

Dianthus Therapeutics, Inc. (DNTH) is emerging as a notable player in the biotechnology sector, captivating the attention of individual investors with its potential to offer significant returns. Specializing in complement..

Auna SA (AUNA) Stock Analysis: Investor Outlook with a 42.86% Potential Upside

Auna SA (AUNA), a Luxembourg-based healthcare service provider, is positioned uniquely within the medical care facilities industry. With operations spanning across Mexico, Peru, and Colombia, Auna delivers a broad array..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Market with a 20.7% Upside Potential

AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, particularly within the medical care facilities industry, presents a compelling case for investors looking to navigate the complexities..

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds